Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2017

Open Access 01-12-2017 | Research

Health-related quality of life and health preference of Chinese patients with diabetes mellitus managed in primary care and secondary care setting: decrements associated with individual complication and number of complications

Authors: Fangfang Jiao, Carlos King Ho Wong, Rita Gangwani, Kathryn Choon Beng Tan, Sydney Chi Wai Tang, Cindy Lo Kuen Lam

Published in: Health and Quality of Life Outcomes | Issue 1/2017

Login to get access

Abstract

Background

Health-related quality of life (HRQoL) and health preference of patients with diabetes mellitus (DM) are essential in health economic evaluations but data on Chinese population is rare. This study aims to evaluate HRQoL and health preference of diabetic patients with different diabetic complications in Chinese population.

Methods

A cross-sectional study was conducted in 1275 patients with DM, including 518 subjects with various DM-related complications. HRQoL and health preference were estimated using SF-12 and SF-6D questionnaires, respectively. Disease status of DM and complications were identified from documented clinical diagnosis. Multivariable regression was used to investigate the effects of specific complications on HRQoL and health preference, adjusting for socio-demographic and clinical parameters.

Results

The presence of any diabetic complication was associated with lower physical component summary (−3.81 points, P < 0.01), and end-stage renal disease (ESRD) showed greatest reduction (−7.05 points, P < 0.01). Mental component summary and mental health (MH) scores were not decreased in any of the diabetic complications. The health preference score for diabetic subjects without complications was 0.882 (95% CI, 0.778 to 0.989). The reductions of health preference score were significant for stroke (−0.042, 95% CI -0.072 to −0.012), ESRD (−0.055, 95% CI -0.093 to −0.017), and sight-threatening diabetic retinopathy (STDR) (−0.043, 95% CI -0.075 to −0.010), while heart disease had an insignificant reduction (−0.017, 95% CI -0.042 to 0.008).

Conclusions

The presence of any of the four major diabetic complications (heart disease, stroke, ESRD and STDR) was associated with lower HRQoL and health preference scores. Findings of this study facilitated the cost-effectiveness studies of alternative management strategies for prevention of diabetic complications in Chinese population.
Appendix
Available only for authorised users
Literature
1.
Guariguata L, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137–49.CrossRefPubMed
2.
3.
Miller RG, et al. Improvements in the life expectancy of type 1 diabetes the Pittsburgh Epidemiology of Diabetes Complications Study Cohort. Diabetes. 2012;61(11):2987–92.CrossRefPubMedPubMedCentral
4.
Rubin RR. Diabetes and quality of life. Diabetes Spectrum. 2000;13(1):21.
5.
Sinnott P, Joyce V, Barnett P. Preference Measurement in Economic Analysis: Guidebook. Menlo Park: Veterans Administration Palo Alto. Health Economics Resource Center; 2007.
6.
Longworth L, Rowen D. Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. Value Health. 2013;16(1):202–10.CrossRefPubMed
7.
Alonso J, et al. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res. 2004;13(2):283–98.CrossRefPubMed
8.
Clarke P, et al. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabet Med. 2003;20(6):442–50.CrossRefPubMed
9.
Holmes J, et al. Health-related Quality of Life in Type 2 Diabetes (T2ARDIS-2). Value Health. 2000;3(s1):47–51.CrossRefPubMed
10.
Lam CL, Lauder IJ. The impact of chronic diseases on the health-related quality of life (HRQOL) of Chinese patients in primary care. Fam Pract. 2000;17(2):159–66.CrossRefPubMed
11.
Venkataraman K, et al. Associations between complications and health-related quality of life in individuals with diabetes. Clin Endocrinol. 2013;78(6):865–73.CrossRef
12.
13.
Quah JH, et al. Health-related quality of life is associated with diabetic complications, but not with short-term diabetic control in primary care. Annals of the Academy of Medicine-Singapore. 2011;40(6):276.
14.
Rejeski WJ, et al. Correlates of Health-Related Quality of Life in Overweight and Obese Adults with Type 2 Diabetes. Obesity. 2006;14(5):870–83.CrossRefPubMed
15.
Wermeling PR, et al. Both cardiovascular and non-cardiovascular comorbidity are related to health status in well-controlled type 2 diabetes patients: a cross-sectional analysis. Cardiovasc Diabetol. 2012;11:121.CrossRefPubMedPubMedCentral
16.
Cong JY, et al. Health-related quality of life among Tianjin Chinese patients with type 2 diabetes: A cross-sectional survey. Nursing & health sciences. 2012;14(4):528–34.CrossRef
17.
Zhang P, et al. Health utility scores for people with type 2 diabetes in US managed care health plans results from Translating Research Into Action for Diabetes (TRIAD). Diabetes Care. 2012;35(11):2250–6.CrossRefPubMedPubMedCentral
18.
Solli O, Stavem K, Kristiansen I. Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health Qual Life Outcomes. 2010;8(1):18.CrossRefPubMedPubMedCentral
19.
Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Mak. 2002;22(4):340–9.CrossRef
20.
Beaudet A, et al. Review of utility values for economic modeling in type 2 diabetes. Value Health. 2014;17(4):462–70.CrossRefPubMed
21.
Janssen M, et al. The use of the EQ-5D preference-based health status measure in adults with type 2 diabetes mellitus. Diabet Med. 2011;28(4):395–413.CrossRefPubMed
22.
Lung TW, et al. A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation. Qual Life Res. 2011;20(10):1669–78.CrossRefPubMed
23.
Johnson JA, et al. Valuations of EQ-5D health states: are the United States and United Kingdom different? Med Care. 2005;43(3):221–8.CrossRefPubMed
24.
Luk A, et al. Health-related quality of life in Chinese patients with type 2 diabetes: An analysis of the Joint Asia Diabetes Evaluation (JADE) Program. J Diabetes Metab. 2014;5:333–40.
25.
Pan C-W, et al. Valuing health-related quality of life in type 2 diabetes patients in China. Med Decis Mak. 2016;36(2):234–41.CrossRef
26.
Xie X, Vondeling H. Cost-Utility Analysis of Intensive Blood Glucose Control with Metformin versus Usual Care in Overweight Type 2 Diabetes Mellitus Patients in Beijing, PR China. Value in Health. 2008;11(s1):S23–32.CrossRefPubMed
27.
Palmer JL, et al. Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China. Adv Ther. 2010;27(11):814–27.CrossRefPubMed
28.
Yang L, et al. Cost-effectiveness of switching patients with type 2 diabetes from insulin glargine to insulin detemir in Chinese setting: a health economic model based on the PREDICTIVE study. Value Health. 2012;15(1):S56–9.CrossRefPubMed
29.
30.
31.
Jiao FF, et al. Effects of the Multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) on biomedical outcomes, observed cardiovascular events and cardiovascular risks in primary care: a longitudinal comparative study. Cardiovasc Diabetol. 2014;13(1):127.CrossRefPubMedPubMedCentral
32.
Jiao F, et al. Long-term effects of the multidisciplinary risk assessment and management program for patients with diabetes mellitus (RAMP-DM): a population-based cohort study. Cardiovasc Diabetol. 2015;14(1):105.CrossRefPubMedPubMedCentral
33.
Wong C, et al. Patient Empowerment Programme in primary care reduced all-cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population-based propensity-matched cohort study. Diabetes Obes Metab. 2015;17(2):128–35.CrossRefPubMed
34.
Wong CK, et al. Patient Empowerment Programme (PEP) and Risk of Microvascular Diseases Among Patients With Type 2 Diabetes in Primary Care: A Population-Based Propensity-Matched Cohort Study. Diabetes Care. 2015;38(8):e116–7.CrossRefPubMed
35.
Lam CL, Tse EY, Gandek B. Is the standard SF-12 health survey valid and equivalent for a Chinese population? Qual Life Res. 2005;14(2):539–47.CrossRefPubMed
36.
Wong C, et al. The associations of body mass index with physical and mental aspects of health-related quality of life in Chinese patients with type 2 diabetes mellitus: results from a cross-sectional survey. Health Qual Life Outcomes. 2013;11(1):142.CrossRefPubMedPubMedCentral
37.
Wong CK, et al. Increased number of structured diabetes education attendance was not associated with the improvement in patient-reported health-related quality of life: results from Patient Empowerment Programme (PEP). Health Qual Life Outcomes. 2015;13(1):126.CrossRefPubMedPubMedCentral
38.
Lam C, et al. Population norm of Chinese (HK) SF-12 health survey-version 2 of Chinese adults in Hong Kong. Hong Kong Practitioner. 2010;32(2):77–86.
39.
Marra CA, et al. A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Med Care. 2004;42(11):1125–31.
40.
Lam CL, Brazier J, McGhee SM. Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value Health. 2008;11(2):295–303.CrossRefPubMed
41.
McGhee S, et al. Quality-adjusted life years: population-specific measurement of the quality component. Hong Kong medical journal. 2011;17:17–21.PubMed
42.
Li L, Fu AZ. Some methodological issues with the analysis of preference-based EQ-5D index score. Health Services and Outcomes Research Methodology. 2009;9(3):162–76.CrossRef
43.
Huang I, et al. Addressing ceiling effects in health status measures: a comparison of techniques applied to measures for people with HIV disease. Health services research. 2008;43(1p1):327–39.CrossRefPubMedPubMedCentral
44.
Pullenayegum EM, et al. Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate? Value Health. 2010;13(4):487–94.CrossRefPubMed
45.
Oliva J, Fernández-Bolaños A, Hidalgo Á. Health-related quality of life in diabetic people with different vascular risk. BMC Public Health. 2012;12(1):812.CrossRefPubMedPubMedCentral
46.
Wee H-L, et al. The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: Is the whole greater than the sum of its parts? Health Qual Life Outcomes. 2005;3(1):2.CrossRefPubMedPubMedCentral
47.
Maddigan SL, Feeny DH, Johnson JA. Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey. Qual Life Res. 2005;14(5):1311–20.CrossRefPubMed
48.
Poljičanin T, et al. Diabetes mellitus and hypertension have comparable adverse effects on health-related quality of life. BMC Public Health. 2010;10(1):12.CrossRefPubMedPubMedCentral
49.
Imazu MFM, et al. Effectiveness of individual and group interventions for people with type 2 diabetes. Revista latino-americana de enfermagem. 2015;23(2):200–7.CrossRefPubMedPubMedCentral
50.
Lloyd A, Sawyer W, Hopkinson P. Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value Health. 2001;4(5):392–400.CrossRefPubMed
51.
Luk AO, et al. Health-related quality of life in Chinese patients with type 2 diabetes: An analysis of the Joint Asia Diabetes Evaluation (JADE) Program. J Diabetes Metab. 2014;2014
52.
Doyle S, et al. A systematic review and critical assessment of health state utilities. PharmacoEconomics. 2012;30(12):1133–43.CrossRefPubMed
53.
Kortt MA, Clarke PM. Estimating utility values for health states of overweight and obese individuals using the SF-36. Qual Life Res. 2005;14(10):2177–85.CrossRefPubMed
54.
Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92.CrossRefPubMed
Metadata
Title
Health-related quality of life and health preference of Chinese patients with diabetes mellitus managed in primary care and secondary care setting: decrements associated with individual complication and number of complications
Authors
Fangfang Jiao
Carlos King Ho Wong
Rita Gangwani
Kathryn Choon Beng Tan
Sydney Chi Wai Tang
Cindy Lo Kuen Lam
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2017
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-017-0699-4

Other articles of this Issue 1/2017

Health and Quality of Life Outcomes 1/2017 Go to the issue

Research

Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment

Research

How great is the medical burden of disease on the aged? Research based on “System of Health Account 2011”

Research

International comparison of experience-based health state values at the population level

Research

Cross-cultural validation of simplified Chinese version of spine functional index

Research

Role of self-efficacy and social support in short-term recovery after total hip replacement: a prospective cohort study

Erratum

Erratum to: Validation of the German version of two scales (RIS, RCS-HCP) for measuring regret associated with providing healthcare